Inclusion body myositis in HIV-1 and HTLV-1 infected patients

Brain

Volumn 119, Issue 6, 1996, Pages 1887-1893

  Cupler, Edward J ^a   Leon Monzon, Marta ^a   Miller, J ^b   Semino Mora, Cristina ^a   Anderson, Thomas L ^b   Dalakas, Marinos C ^a,c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c National Institute of Neurological Disorders   (United States)

Author keywords

HIV 1; HTLV 1; Inclusion body myositis; Superantigen

Indexed keywords

AMYLOID; ANTIVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN T CELL LEUKEMIA VIRUS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECEPTOR SUBUNIT; T LYMPHOCYTE RECEPTOR; ZIDOVUDINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CELL VACUOLE; CLINICAL FEATURE; ELECTRON MICROSCOPY; EOSINOPHIL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INCLUSION BODY MYOSITIS; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROSCOPY; MUSCLE BIOPSY; MUSCLE CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MYOSITIS, INCLUSION BODY; RECEPTORS, ANTIGEN, T-CELL;

EID: 0030453469     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.6.1887     Document Type: Article

References (27)

1. Aguzzi A, Bothe K, Anhauser I, Horak I, Rethwilm A, Wagner EF. Expression of human foamy virus is differentially regulated during development in transgenic mice. New Biol 1992; 4: 225-37.
2. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16: 193-208.
3. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I. Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 1991; 253: 555-7.
4. Dalakas MC. Polymyositis. dermatomyositis and inclusion-body myositis [see comments]. N Engl J Med 1991; 325: 1487-98. Comment in: N Engl J Med 1992; 326: 1293.
5. Dalakas MC. Polymyositis. dermatomyositis and inclusion-body myositis [see comments]. N Engl J Med 1991; 325: 1487-98. Comment in: N Engl J Med 1992; 326: 1293.
6. Dalakas MC, London WT, Gravell M, Sever JL. Polymyositis in an immunodeficiency disease in monkeys induced by a type D retrovirus. Neurology 1986a; 36: 569-72.
7. Dalakas MC, Pezeshkpour GH, Gravell M, Sever JL. Polymyositis in patients with AIDS. JAMA 1986b; 256: 2381-3.
8. Dalakas MC, Gravell M, London WT, Cunningham G, Sever JL. Morphological changes of an inflammatory myopathy in rhesus monkeys with simian acquired immunodeficiency syndrome. Proc Soc Exp Biol Med 1987; 185: 368-76.
9. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984; 16: 209-15.
10. Herman A, Kappler JW, Marrack P, Pullen AM. Superantigens: mechanism of T-cell stimulation and role in immune responses. [Review]. Annu Rev Immunol 1991; 9: 745-72.
11. Higuchi I, Nerenberg M, Yoshimine K, Yoshida M, Fukunaga H, Tajima K, et al. Failure to detect HTLV-1 by in situ hybridization in the biopsied muscles of viral carriers with polymyositis. Muscle Nerve 1992; 15: 43-7.
12. Hohlfeld R, Engel AG. Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am J Pathol 1990; 136: 503-8.
13. Illa I, Nath A, Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 1991; 29: 474-81.
14. Illa I, Leon-Monzon M, Dalakas M. Retroviral sequences in patients with polymyositis (PM), dermatomyositis (DM), and inclusion body myositis (IBM) [abstract]. Neurology 1992; 42 Suppl 3: 302.
15. Karpati G, Carpenter S. Pathology of the inflammatory myopathies. [Review]. Baillieres Clin Neurol 1993; 2: 527-56.
16. Lamperth L, Vicenzi E, Dalakas M. Infection and transfection of human muscle by HIV or HIV proviral-DNA construct [abstract]. Neurology 1991; 41 Suppl 1: 211.
17. Leon-Monzon M, Illa I, Dalakas MC. Polymyositis in patients infected with human T-cell leukemia virus type 1 : the role of the virus in the cause of the disease. Ann Neurol 1994; 36: 643-9.
18. Leon-Monzon M, Lamperth L, Dalakas MC. Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis. Muscle Nerve 1993; 16: 408-13.
19. Lindberg C, Oldfors A, Tarkowski A. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies. Eur J Immunol 1994; 24: 2659-63.
20. London WT, Sever JL, Madden DL, Henrickson RV, Gravell M, Maul DH, Dalakas MC, et al. Experimental transmission of simian acquired immunodeficiency syndrome (SAIDS) and Kaposi-like skin lesions. Lancet 1983; 2: 869-73.
21. Mikol J, Engel AG. Inclusion body myositis. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill, 1994: 1384-98.
22. Morgan OS, Rogers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989; 2: 1184-7.
23. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. The αβ T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes. J Autoimmun 1994; 7: 321-33.
24. Pantaleo G, Graziosi C, Fauci AS. New concepts in the immunopathogenesis of human immunodeficiency virus infection. [Review]. N Engl J Med 1993; 328: 327-35.
25. Rowland LP. Polymyositis, inclusion body myositis, and related myopathies. In: Rowland LP, editor. Merritt's textbook of neurology. 9th ed. Baltimore: Williams and Wilkins, 1995: 798-802.
26. Said JW, Shintaku IP, Parekh K, Pinkus GS. Specific phenotyping of T-cell proliferations in formalin-fixed paraffin-embedded tissues. Use of antibodies to the T-cell receptor βF1. Am J Clin Pathol 1990; 93: 382-6.
27. Sekul EA, Dalakas MC. Inclusion body myositis: new concepts. [Review]. Semin Neurol 1993; 13: 256-63.